Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
复制标题
DOI:
10.1007/s12035-014-8657-1
复制
发表时间:
2014-10
影响因子:
5.1
通讯作者:
Heneka, Michael T.
中科院分区:
文献类型:
--
作者:
Brosseron, Frederic;Krauthausen, Marius;Kummer, Markus;Heneka, Michael T.
This article gives a comprehensive overview of cytokine and other inflammation associated protein levels in plasma, serum and cerebrospinal fluid (CSF) of patients with Alzheimer’s disease (AD) and mild cognitive impairment (MCI). We reviewed 118 research articles published between 1989 and 2013 to compare the reported levels of 66 cytokines and other proteins related to regulation and signaling in inflammation in the blood or CSF obtained from MCI and AD patients. Several cytokines are evidently regulated in (neuro-) inflammatory processes associated with neurodegenerative disorders. Others do not display changes in the blood or CSF during disease progression. However, many reports on cytokine levels in MCI or AD are controversial or inconclusive, particularly those which provide data on frequently investigated cytokines like tumor necrosis factor alpha (TNF-α) or interleukin-6 (IL-6). The levels of several cytokines are possible indicators of neuroinflammation in AD. Some of them might increase steadily during disease progression or temporarily at the time of MCI to AD conversion. Furthermore, elevated body fluid cytokine levels may correlate with an increased risk of conversion from MCI to AD. Yet, research results are conflicting. To overcome interindividual variances and to obtain a more definite description of cytokine regulation and function in neurodegeneration, a high degree of methodical standardization and patients collective characterization, together with longitudinal sampling over years is essential. The online version of this article (doi:10.1007/s12035-014-8657-1) contains supplementary material, which is available to authorized users.
登录
查看更多内容
DOI:
10.1016/s0140-6736(20)32205-4
发表时间:
2021-04-24
期刊:
Lancet (London, England)
影响因子:
--
作者:
Scheltens P;De Strooper B;Kivipelto M;Holstege H;Chételat G;Teunissen CE;Cummings J;van der Flier WM
通讯作者:
van der Flier WM
影响因子:
2.4
作者:
Blasko, I;Lederer, W;Humpel, C
通讯作者:
Humpel, C
DOI:
10.3988/jcn.2008.4.2.84
发表时间:
2008-06
期刊:
Journal of clinical neurology (Seoul, Korea)
影响因子:
--
作者:
Choi C;Jeong JH;Jang JS;Choi K;Lee J;Kwon J;Choi KG;Lee JS;Kang SW
通讯作者:
Kang SW
影响因子:
0.8
作者:
Bettcher BM;Kramer JH
通讯作者:
Kramer JH
影响因子:
3.7
作者:
Bjorkqvist, Maria;Ohlsson, Mattias;Hansson, Oskar
通讯作者:
Hansson, Oskar